✦ LIBER ✦

Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices

✍ Scribed by Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael A.

Book ID: 122841866
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 398 KB
Volume: 184
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.06.149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bacillus calmette-Guérin plus intravesic

Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

✍ Phillip Stricker; Kimberley Pryor; Timothy Nicholson; David Goldstein; David Gol 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Phase I Trial of Intravesical Recombinan

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

✍ Dinney, Colin P.N.; Fisher, Mark B.; Navai, Neema; O'Donnell, Michael A.; Cutler 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 964 KB

Usefulness of the Spanish Urological Clu

Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α

✍ Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 128 KB

Bacillus Calmette-Guérin With or Without

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

✍ Nepple, Kenneth G.; Lightfoot, Andrew J.; Rosevear, Henry M.; O'Donnell, Michael 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 252 KB

Bacillus calmete-guérin plus interferon-

Bacillus calmete-guérin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

✍ John S. Lam; Mitchell C. Benson; Michael A. O’Donnell; Alexandra Sawczuk; Anna G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Efficacy and Safety of MCNA in Patients

Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guérin

✍ Morales, Alvaro; Herr, Harry; Steinberg, Gary; Given, Robert; Cohen, Zvi; Amrhei 📂 Article 📅 2015 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 285 KB